Biostar Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jan '26 Jan 29, 2026	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Market Capitalization	0	8	6	18	26	10
Market Cap Growth	-99.86%	24.45%	-65.71%	-29.15%	155.73%	-42.84%
Enterprise Value	-	9	9	14	20	-2
Last Close Price	0.00	2.93	2.81	8.19	14.49	7.00
PE Ratio	0.00	-	-	3.74	31.59	-
PS Ratio	0.00	3.24	0.23	0.30	0.49	0.20
PB Ratio	0.00	0.21	0.14	0.25	0.41	0.17
P/TBV Ratio	0.00	0.25	0.17	0.31	0.56	0.21
P/FCF Ratio	-	1.57	1.07	41.02	3.22	-
P/OCF Ratio	0.00	1.57	1.06	5.47	2.87	-
EV/Sales Ratio	-	3.98	0.33	0.22	0.38	-
EV/EBITDA Ratio	-	-	-	3.09	5.63	-
EV/EBIT Ratio	-	-	-	10.39	26.58	-
EV/FCF Ratio	-	1.93	1.53	30.72	2.51	-
Debt / Equity Ratio	0.07	0.06	0.06	0.04	-	0.11
Debt / EBITDA Ratio	0.62	-	-	0.70	-	-
Debt / FCF Ratio	0.28	0.47	0.48	7.01	-	-
Asset Turnover	0.01	0.05	0.41	0.83	0.76	0.64
Inventory Turnover	1.16	7.32	35.27	41.40	32.25	17.53
Quick Ratio	0.16	1.28	2.25	3.23	4.57	2.20
Current Ratio	0.19	1.31	2.28	4.90	7.51	3.30
Return on Equity (ROE)	2.66%	-14.04%	-43.07%	7.18%	1.34%	-29.81%
Return on Assets (ROA)	4.25%	-4.75%	-10.25%	1.10%	0.68%	-9.88%
Return on Invested Capital (ROIC)	1.92%	-8.29%	-18.01%	1.87%	0.36%	-19.81%
Return on Capital Employed (ROCE)	7.70%	-9.70%	-24.60%	1.80%	1.20%	-21.00%
Earnings Yield	353921.59%	-73.75%	-404.45%	26.77%	3.17%	-200.10%
FCF Yield	-	63.58%	93.70%	2.44%	31.02%	-36.19%
Buyback Yield / Dilution	-18.37%	-3.91%	-6.74%	-25.96%	-20.27%	-2.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.